New Medication With a Peptide and Hormone can Treat Obesity and Binge Eating Disorders

by Dr. Trupti Shirole on February 6, 2015 at 10:49 AM
 New Medication With a Peptide and Hormone can Treat Obesity and Binge Eating Disorders

Scientists have identified a peptide called pituitary adenylate cyclase-activating peptide (PACAP) and a hormone produced by neurons, in a specific area of the brain called the 'central amygdala', that can reduce hunger cravings and lead to weight loss. This novel study by researchers at Boston University School of Medicine (BUSM) may one day lead to medications that treat obesity and binge eating disorders.

According to the researchers PACAP has been known for its food intake and body weight effects in the hypothalamus (the area of the brain known for controlling appetite). However, this is the first study of PACAP effects in the amygdala, a region of the brain outside the hypothalamus, involved in fear but also in the emotional component of eating.


The researchers also found how PACAP decreases food intake when injected in the amygdala. Researcher Valentina Sabino said, "We found that amygdalar PACAP reduces the amount of food eaten within meals, but not how many meals are consumed. In addition, we also found that PACAP reduced the rate of intake of food. This meant that, following administration of PACAP, models were eating more slowly."

The researchers believe these findings could have implications for a variety of conditions, since they found not only how much food subjects ate but also how fast they ate them. Co-author Pietro Cottone said, "The PACAP system may hypothetically be the target of medications to treat not only obesity but also binge-eating, a disease characterized by excessive, uncontrollable consumption of food within brief periods of time."

The study is published in the journal Neuropsychopharmacology.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Obesity News

How Exercise Improves Obesity-Linked Dementia?
Regular exercise in obese individuals lowers memory loss and cognitive impairment, preventing neurodegenerative disorders including dementia.
Obesity Linked to Poorer Rheumatoid Arthritis Flare Symptoms
Clinicians should take into account patients' BMI and RA-FQ scores when devising treatment strategies for RA flares, suggest researchers.
How Intestinal Glycan Alterations Are Linked to Obesity?
Study reveals the importance of host glycosylation, particularly GlcNAc-6-O-sulfation on intestinal mucins, in safeguarding against obesity and gut inflammation.
Metabolically Healthy Obesity: Truth Vs Myth
Metabolically healthy obesity are obese people with no metabolic complications but are at higher risk of metabolic co-morbidities compared to normal people.
Pathbreaking Anti-Obesity Drug KDS2010 Helps Burn Fat Without Diet Restrictions
KDS2010 drug was found to regulate astrocytes in brain which enhances fat metabolism resulting in weight loss without the need for dietary restrictions.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Medication With a Peptide and Hormone can Treat Obesity and Binge Eating Disorders Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests